Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HeliMeds vs Ilant Health

HeliMeds
Graded #154

Higher grade

vs+11.5
Ilant Health
Graded #408

Lower grade

The verdict

HeliMeds takes it — 68.3/100 to 56.8/100.

HeliMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HeliMeds offers compounded semaglutide and tirzepatide as well as brand-name Wegovy and Zepbound.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHeliMeds +29
74
45
Dose & formulationHeliMeds +37
77
40
Clinical oversightIlant Health +12
71
83
Labs & monitoringIlant Health +9
52
61
FulfillmentHeliMeds +5
67
62
Contract termsEven
55
55
HeliMeds · left barIlant Health · right bar

The numbers

MetricHeliMedsIlant Health
WeighScore68.3/10056.8/100
GradeCC
Scorecard rank#154#408
Semaglutide$1,599/mo (brand Wegovy)Not disclosed
Tirzepatide$149/mo (starting dose, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
HeliMeds

Graded #154 · C

Strengths

  • Both compounded and brand-name GLP-1 options available
  • LegitScript certified (#368688)
  • Compounded semaglutide from $99 — competitive pricing

Where it loses points

  • State availability not publicly disclosed
  • Compounded medications are not FDA-approved (stated on site)
  • Also a broader health platform (sexual health, energy)
Ilant Health

Graded #408 · C

Strengths

  • Value-based, outcomes-driven obesity care model
  • Includes GLP-1 medications with transparent drug pricing for sponsors
  • Care team of board-certified obesity providers and behavioral specialists
  • Dietitians and peer navigators support adherence
  • Data-driven stratification targets the right interventions

Where it loses points

  • Distributed via employers and health plans, not direct cash-pay
  • Individuals generally cannot enroll without sponsor coverage
  • No public consumer pricing for GLP-1
  • Access gated behind organizational buyers
  • Not suited to consumers wanting direct-to-door GLP-1

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard